AMPEL BioSolutions Seeks $12.5M to Market its Personalized Blood Test for Lupus
AMPEL BioSolutions is seeking $12.5 million to market LuGene, a blood test that uses genetic data to predict personal treatment response and lupus flares.
0 Comments